Insider: Dube Eric M CHIEF EXECUTIVE OFFICER - Travere Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 419,173 | 0 | 419,173 |
| Value | $10,353,573.10 | $0.00 | $10,353,573.10 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 05/05/2025 | DDS | 18,924 | Direct | COM | $21.05 | $398,350.20 | 419,173 |
| 02/11/2025 | DDS | 11,375 | Direct | COM | $24.04 | $273,455.00 | 419,173 |
| 02/03/2025 | DDS | 50,691 | Direct | COM | $20.21 | $1,024,343.45 | 430,548 |
| 01/22/2025 | DDS | 10,736 | Direct | COM | $19.46 | $208,922.56 | 351,239 |
| 09/09/2024 | DDS | 21,125 | Direct | COM | $11.52 | $243,360.00 | 361,975 |
| 02/01/2024 | DDS | 9,106 | Direct | COM | $8.53 | $77,693.30 | 360,616 |
| 02/01/2024 | DDS | 10,016 | Direct | COM | $8.86 | $88,741.76 | 350,600 |
| 01/23/2024 | DDS | 7,873 | Direct | COM | $8.96 | $70,542.08 | 234,722 |
| 09/05/2023 | DDS | 4,455 | Direct | COM | $14.71 | $65,533.05 | 242,595 |
| 02/01/2023 | DDS | 8,196 | Direct | COM | $22.25 | $182,361.00 | 237,150 |
| 01/24/2023 | DDS | 6,442 | Direct | COM | $21.50 | $138,503.00 | 147,846 |
| 01/05/2023 | DDS | 5,625 | Direct | COM | $20.75 | $116,718.75 | 154,288 |
| 02/10/2022 | DDS | 4,832 | Direct | COM | $27.84 | $134,522.88 | 159,913 |
| 01/31/2022 | DDS | 4,813 | Direct | COM | $27.40 | $131,876.20 | 164,745 |
| 01/24/2022 | DDS | 7,873 | Direct | COM | $24.98 | $196,667.54 | 131,710 |
| 01/05/2022 | DDS | 10,361 | Direct | COM | $29.84 | $309,172.24 | 141,722 |
| 01/05/2022 | DDS | 2,139 | Direct | COM | $30.48 | $65,196.72 | 139,583 |
| 01/04/2022 | DDS | 4,832 | Direct | COM | $30.43 | $147,037.76 | 152,083 |
| 08/17/2021 | DDS | 7,836 | Direct | COM | $17.12 | $134,142.13 | 156,915 |
| 02/08/2021 | DDS | 4,813 | Direct | COM | $31.58 | $151,994.54 | 156,813 |
| 02/05/2021 | DDS | 4,813 | Direct | COM | $31.41 | $151,176.33 | 161,626 |
| 02/03/2021 | DDS | 2,406 | Direct | COM | $28.91 | $69,557.46 | 148,939 |
| 02/02/2021 | DDS | 6,328 | Direct | COM | $29.60 | $187,282.22 | 153,751 |
| 02/02/2021 | DDS | 2,406 | Direct | COM | $30.75 | $73,984.50 | 151,345 |
| 01/06/2021 | DDS | 3,438 | Direct | COM | $27.01 | $92,860.38 | 87,819 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research